Ertugliflozin is intended for Pharmaceuticals applications as a sodium–glucose cotransporter 2 (SGLT2) inhibitor. It is a medication used to treat the symptoms of Type 2 Diabetes Mellitus (alone or in combination with other antidiabetic drugs). All information about Ertugliflozin is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year